Collaborative effort will accelerate development of novel therapies for underserved diseases involving the central nervous system
Minnetronix Neuro Successfully Completes First Clinical Study in Hemorrhagic Stroke
Minnesota-based Company to Present at Late Breaking Session during Congress of Neurological Surgeons